Jubilant Pharmova Limited — Important, 29-01-2025: General Updates

Jubilant Pharmova Limited has executed definitive agreements through its subsidiary, Jubilant Biosys Innovative Research Services Pte Limited (JBIRSPL), to acquire an 80% stake in JASMIN, a newly formed company in France, from Pierre Fabre SA and its affiliates. As part of this transaction, JASMIN will take over Pierre Fabre's R&D Center in Saint Julien, France. The acquisition has received a green light from the French Ministry of Economy and Finance, confirming it is free from foreign investment control. This strategic move enhances Jubilant's research capabilities and aligns with long-term growth objectives, marking a significant step in expanding their international presence and innovation capacity. Investors should consider this acquisition's potential to strengthen Jubilant’s market position and foster future growth opportunities.